[1] |
王靖宇,常宝成. 高尿酸血症/痛风流行病学特点及危险因素[J]. 国际内分泌代谢杂志,2016,36(2):78-81,88. DOI:10.3760/cma.j.issn.1673-4157.2016.02.002.
|
[2] |
LIU R, HAN C, WU D,et al. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014:a systematic review and meta-analysis[J]. Biomed Res Int,2015,2015:762820. DOI:10.1155/2015/762820.
|
[3] |
中华医学会内分泌学分会. 中国高尿酸血症与痛风诊疗指南(2019)[J]. 中华内分泌代谢杂志,2020,36(1):1-13. DOI:10.3760/cma.j.issn.1000-6699.2020.01.001.
|
[4] |
高尿酸血症相关疾病诊疗多学科共识专家组. 中国高尿酸血症相关疾病诊疗多学科专家共识[J]. 中华内科杂志,2017,56(3):235-248. DOI:10.3760/cma.j.issn.0578-1426.2017.03.021.
|
[5] |
LUIS-RODRÍGUEZ D, DONATE-CORREA J, MARTÍN-NÚÑEZ E,et al. Serum urate is related to subclinical inflammation in asymptomatic hyperuricaemia[J]. Rheumatology:Oxford,2021,60(1):371-379. DOI:10.1093/rheumatology/keaa425.
|
[6] |
WANG H Y, SHI W R, YI X,et al. Assessing the performance of monocyte to high-density lipoprotein ratio for predicting ischemic stroke:insights from a population-based Chinese cohort[J]. Lipids Heal Dis,2019,18(1):127. DOI:10.1186/s12944-019-1076-6.
|
[7] |
SHI W R, WANG H Y, CHEN S,et al. The impact of monocyte to high-density lipoprotein ratio on reduced renal function:insights from a large population[J]. Biomark Med,2019,13(9):773-783. DOI:10.2217/bmm-2018-0406.
|
[8] |
ZHANG Y, LI S, GUO Y L,et al. Is monocyte to HDL ratio superior to monocyte count in predicting the cardiovascular outcomes:evidence from a large cohort of Chinese patients undergoing coronary angiography[J]. Ann Med,2016,48(5):305-312. DOI:10.3109/07853890.2016.1168935.
|
[9] |
FAN J G, WEI L, ZHUANG H,et al. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018,China)[J]. J Dig Dis,2019,20(4):163-173. DOI:10.1111/1751-2980.12685.
|
[10] |
ZHANG W Z. Intensified,optimized and standardized management of Chinese patients with hypertension:comments on "2018 Chinese Guidelines for Prevention and Treatment of Hypertension" [J]. J Geriatr Cardiol,2019,16(3):178-181. DOI:10.11909/j.issn.1671-5411.2019.03.013.
|
[11] |
JUNG S W, KIM S M, KIM Y G,et al. Uric acid and inflammation in kidney disease[J]. Am J Physiol Ren Physiol,2020,318(6):F1327-1340. DOI:10.1152/ajprenal.00272.2019.
|
[12] |
LU W J, XU Y Z, SHAO X N,et al. Uric acid produces an inflammatory response through activation of NF-κB in the hypothalamus:implications for the pathogenesis of metabolic disorders[J]. Sci Rep,2015,5:12144. DOI:10.1038/srep12144.
|
[13] |
TOMIYAMA H, SHIINA K, VLACHOPOULOS C,et al. Involvement of arterial stiffness and inflammation in hyperuricemia-related development of hypertension[J]. Hypertension,2018,72(3):739-745. DOI:10.1161/HYPERTENSIONAHA.118.11390.
|
[14] |
KUNDI, GOK M, KIZILTUNC E,et al. Relation between monocyte to high-density lipoprotein cholesterol ratio with presence and severity of isolated coronary artery ectasia[J]. Am J Cardiol,2015,116(11):1685-1689. DOI:10.1016/j.amjcard.2015.08.036.
|
[15] |
AÇIKGÖZ S K, AÇIKGÖZ E, SENSOY B,et al. Monocyte to high-density lipoprotein cholesterol ratio is predictive of in-hospital and five-year mortality in ST-segment elevation myocardial infarction[J]. Cardiol J,2016,23(5):505-512. DOI:10.5603/CJ.a2016.0026.
|
[16] |
MURPHY A J, WOOLLARD K J, HOANG A,et al. High-density lipoprotein reduces the human monocyte inflammatory response[J]. Arterioscler Thromb Vasc Biol,2008,28(11):2071-2077. DOI:10.1161/ATVBAHA.108.168690.
|
[17] |
GHATTAS A, GRIFFITHS H R, DEVITT A,et al. Monocytes in coronary artery disease and atherosclerosis:where are we now?[J]. J Am Coll Cardiol,2013,62(17):1541-1551. DOI:10.1016/j.jacc.2013.07.043.
|
[18] |
KRYCHTIUK K A, KASTL S P, HOFBAUER S L,et al. Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a)[J]. J Clin Lipidol,2015,9(4):533-541. DOI:10.1016/j.jacl.2015.04.005.
|
[19] |
MURPHY A J, WOOLLARD K J, HOANG A,et al. High-density lipoprotein reduces the human monocyte inflammatory response[J]. Arterioscler Thromb Vasc Biol,2008,28(11):2071-2077. DOI:10.1161/ATVBAHA.108.168690.
|
[20] |
PARTHASARATHY S, BARNETT J, FONG L G. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein[J]. Biochim Biophys Acta,1990,1044(2):275-283. DOI:10.1016/0005-2760(90)90314-n.
|
[21] |
ZHANG L, WAN Q L, ZHOU Y M,et al. Age-related and gender-stratified differences in the association between high triglyceride and risk of hyperuricemia[J]. Lipids Health Dis,2019,18(1):147. DOI:10.1186/s12944-019-1077-5.
|
[22] |
YU X L, SHU L, SHEN X M,et al. Gender difference on the relationship between hyperuricemia and nonalcoholic fatty liver disease among Chinese:an observational study[J]. Medicine (Baltimore),2017,96(39):e8164. DOI:10.1097/MD.0000000000008164.
|
[23] |
WALLACE I R, MCKINLEY M C, BELL P M,et al. Sex hormone binding globulin and insulin resistance[J]. Clin Endocrinol:Oxf,2013,78(3):321-329. DOI:10.1111/cen.12086.
|